These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 12717424)
1. Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development. Halkidou K; Gnanapragasam VJ; Mehta PB; Logan IR; Brady ME; Cook S; Leung HY; Neal DE; Robson CN Oncogene; 2003 Apr; 22(16):2466-77. PubMed ID: 12717424 [TBL] [Abstract][Full Text] [Related]
2. Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleus. Shiota M; Yokomizo A; Masubuchi D; Tada Y; Inokuchi J; Eto M; Uchiumi T; Fujimoto N; Naito S Prostate; 2010 Apr; 70(5):540-54. PubMed ID: 19938016 [TBL] [Abstract][Full Text] [Related]
3. Expression and function of androgen receptor coactivators in prostate cancer. Culig Z; Comuzzi B; Steiner H; Bartsch G; Hobisch A J Steroid Biochem Mol Biol; 2004 Nov; 92(4):265-71. PubMed ID: 15663989 [TBL] [Abstract][Full Text] [Related]
4. ING3 promotes prostate cancer growth by activating the androgen receptor. Nabbi A; McClurg UL; Thalappilly S; Almami A; Mobahat M; Bismar TA; Binda O; Riabowol KT BMC Med; 2017 May; 15(1):103. PubMed ID: 28511652 [TBL] [Abstract][Full Text] [Related]
5. Altered corepressor SMRT expression and recruitment to target genes as a mechanism that change the response to androgens in prostate cancer progression. Godoy AS; Sotomayor PC; Villagran M; Yacoub R; Montecinos VP; McNerney EM; Moser M; Foster BA; Onate SA Biochem Biophys Res Commun; 2012 Jul; 423(3):564-70. PubMed ID: 22695118 [TBL] [Abstract][Full Text] [Related]
6. Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. Gaughan L; Logan IR; Cook S; Neal DE; Robson CN J Biol Chem; 2002 Jul; 277(29):25904-13. PubMed ID: 11994312 [TBL] [Abstract][Full Text] [Related]
7. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth. Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860 [TBL] [Abstract][Full Text] [Related]
8. Androgen receptor requires JunD as a coactivator to switch on an oxidative stress generation pathway in prostate cancer cells. Mehraein-Ghomi F; Basu HS; Church DR; Hoffmann FM; Wilding G Cancer Res; 2010 Jun; 70(11):4560-8. PubMed ID: 20460526 [TBL] [Abstract][Full Text] [Related]
9. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Gregory CW; Hamil KG; Kim D; Hall SH; Pretlow TG; Mohler JL; French FS Cancer Res; 1998 Dec; 58(24):5718-24. PubMed ID: 9865729 [TBL] [Abstract][Full Text] [Related]
11. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
12. The Molecular Effects of Sulforaphane and Capsaicin on Metabolism upon Androgen and Tip60 Activation of Androgen Receptor. Carrasco-Pozo C; Tan KN; Rodriguez T; Avery VM Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671779 [TBL] [Abstract][Full Text] [Related]
13. Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Gnanapragasam VJ; Robson CN; Neal DE; Leung HY Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer. Liu Y; Majumder S; McCall W; Sartor CI; Mohler JL; Gregory CW; Earp HS; Whang YE Cancer Res; 2005 Apr; 65(8):3404-9. PubMed ID: 15833875 [TBL] [Abstract][Full Text] [Related]
15. ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes. Zou JX; Zhong Z; Shi XB; Tepper CG; deVere White RW; Kung HJ; Chen H Prostate; 2006 Oct; 66(14):1474-86. PubMed ID: 16921507 [TBL] [Abstract][Full Text] [Related]
16. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines. Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788 [TBL] [Abstract][Full Text] [Related]
17. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer. Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446 [TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142 [TBL] [Abstract][Full Text] [Related]
19. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464 [TBL] [Abstract][Full Text] [Related]
20. In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis. Chesire DR; Ewing CM; Gage WR; Isaacs WB Oncogene; 2002 Apr; 21(17):2679-94. PubMed ID: 11965541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]